aluates Reports

$ 0.0

Automative

Global Ciclopirox Olamine Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-2R6233

Global Ciclopirox Olamine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Ciclopirox Olamine Market Research Report 2025

Code: QYRE-Auto-2R6233

Report

September 2025

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Apotex Corporation

Fougera (Sandoz)

Medimetriks Pharmaceuticals

Taro Pharmaceuticals

Preferred Pharmaceuticals

Ingenus Pharmaceuticals

Alvogen (CVC Capital Partners and Temasek )

Acella Pharmaceuticals

Dr Marc's Manufacturing

Paddock Laboratories (Perrigo)

Sincerus

Glades Pharmaceuticals (GSK)

Sterimax

Guangzhou Kanghe Pharmaceutical

Tianjin Lisheng Pharmaceutical

Zhejiang Xianju Pharmaceutical

Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

Ciclopirox Olamine Market

The global market for Ciclopirox Olamine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor.

North American market for Ciclopirox Olamine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Ciclopirox Olamine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Ciclopirox Olamine in Ringworm Of The Body is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Ciclopirox Olamine include Bayer, Apotex Corporation, Fougera (Sandoz), Medimetriks Pharmaceuticals, Taro Pharmaceuticals, Preferred Pharmaceuticals, Ingenus Pharmaceuticals, Alvogen (CVC Capital Partners and Temasek ), Acella Pharmaceuticals, Dr Marc's Manufacturing, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Ciclopirox Olamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclopirox Olamine.

The Ciclopirox Olamine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ciclopirox Olamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ciclopirox Olamine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ciclopirox Olamine Market Report

Report Metric	Details
Report Name	Ciclopirox Olamine Market
Segment by Type	Cream Preparation Temperture Vaginal Suppository
Segment by Application	Ringworm Of The Body Athlete'S Foot Tinea Tinea Versicolor Candida Albicans Gynecological Anti-Infection Preparation Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Apotex Corporation, Fougera (Sandoz), Medimetriks Pharmaceuticals, Taro Pharmaceuticals, Preferred Pharmaceuticals, Ingenus Pharmaceuticals, Alvogen (CVC Capital Partners and Temasek ), Acella Pharmaceuticals, Dr Marc's Manufacturing, Paddock Laboratories (Perrigo), Sincerus, Glades Pharmaceuticals (GSK), Sterimax, Guangzhou Kanghe Pharmaceutical, Tianjin Lisheng Pharmaceutical, Zhejiang Xianju Pharmaceutical, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ciclopirox Olamine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ciclopirox Olamine Market report?

Ans: The main players in the Ciclopirox Olamine Market are Bayer, Apotex Corporation, Fougera (Sandoz), Medimetriks Pharmaceuticals, Taro Pharmaceuticals, Preferred Pharmaceuticals, Ingenus Pharmaceuticals, Alvogen (CVC Capital Partners and Temasek ), Acella Pharmaceuticals, Dr Marc's Manufacturing, Paddock Laboratories (Perrigo), Sincerus, Glades Pharmaceuticals (GSK), Sterimax, Guangzhou Kanghe Pharmaceutical, Tianjin Lisheng Pharmaceutical, Zhejiang Xianju Pharmaceutical, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

What are the Application segmentation covered in the Ciclopirox Olamine Market report?

Ans: The Applications covered in the Ciclopirox Olamine Market report are Ringworm Of The Body, Athlete'S Foot, Tinea, Tinea Versicolor, Candida Albicans, Gynecological Anti-Infection Preparation, Other

What are the Type segmentation covered in the Ciclopirox Olamine Market report?

Ans: The Types covered in the Ciclopirox Olamine Market report are Cream Preparation, Temperture, Vaginal Suppository

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ciclopirox Olamine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cream Preparation

1.2.3 Temperture

1.2.4 Vaginal Suppository

1.3 Market by Application

1.3.1 Global Ciclopirox Olamine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Ringworm Of The Body

1.3.3 Athlete'S Foot

1.3.4 Tinea

1.3.5 Tinea Versicolor

1.3.6 Candida Albicans

1.3.7 Gynecological Anti-Infection Preparation

1.3.8 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ciclopirox Olamine Market Perspective (2020-2031)

2.2 Global Ciclopirox Olamine Growth Trends by Region

2.2.1 Global Ciclopirox Olamine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Ciclopirox Olamine Historic Market Size by Region (2020-2025)

2.2.3 Ciclopirox Olamine Forecasted Market Size by Region (2026-2031)

2.3 Ciclopirox Olamine Market Dynamics

2.3.1 Ciclopirox Olamine Industry Trends

2.3.2 Ciclopirox Olamine Market Drivers

2.3.3 Ciclopirox Olamine Market Challenges

2.3.4 Ciclopirox Olamine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ciclopirox Olamine Players by Revenue

3.1.1 Global Top Ciclopirox Olamine Players by Revenue (2020-2025)

3.1.2 Global Ciclopirox Olamine Revenue Market Share by Players (2020-2025)

3.2 Global Ciclopirox Olamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Ciclopirox Olamine Revenue

3.4 Global Ciclopirox Olamine Market Concentration Ratio

3.4.1 Global Ciclopirox Olamine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ciclopirox Olamine Revenue in 2024

3.5 Global Key Players of Ciclopirox Olamine Head office and Area Served

3.6 Global Key Players of Ciclopirox Olamine, Product and Application

3.7 Global Key Players of Ciclopirox Olamine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Ciclopirox Olamine Breakdown Data by Type

4.1 Global Ciclopirox Olamine Historic Market Size by Type (2020-2025)

4.2 Global Ciclopirox Olamine Forecasted Market Size by Type (2026-2031)

5 Ciclopirox Olamine Breakdown Data by Application

5.1 Global Ciclopirox Olamine Historic Market Size by Application (2020-2025)

5.2 Global Ciclopirox Olamine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Ciclopirox Olamine Market Size (2020-2031)

6.2 North America Ciclopirox Olamine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Ciclopirox Olamine Market Size by Country (2020-2025)

6.4 North America Ciclopirox Olamine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ciclopirox Olamine Market Size (2020-2031)

7.2 Europe Ciclopirox Olamine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Ciclopirox Olamine Market Size by Country (2020-2025)

7.4 Europe Ciclopirox Olamine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ciclopirox Olamine Market Size (2020-2031)

8.2 Asia-Pacific Ciclopirox Olamine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Ciclopirox Olamine Market Size by Region (2020-2025)

8.4 Asia-Pacific Ciclopirox Olamine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ciclopirox Olamine Market Size (2020-2031)

9.2 Latin America Ciclopirox Olamine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Ciclopirox Olamine Market Size by Country (2020-2025)

9.4 Latin America Ciclopirox Olamine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ciclopirox Olamine Market Size (2020-2031)

10.2 Middle East & Africa Ciclopirox Olamine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Ciclopirox Olamine Market Size by Country (2020-2025)

10.4 Middle East & Africa Ciclopirox Olamine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Ciclopirox Olamine Introduction

11.1.4 Bayer Revenue in Ciclopirox Olamine Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Apotex Corporation

11.2.1 Apotex Corporation Company Details

11.2.2 Apotex Corporation Business Overview

11.2.3 Apotex Corporation Ciclopirox Olamine Introduction

11.2.4 Apotex Corporation Revenue in Ciclopirox Olamine Business (2020-2025)

11.2.5 Apotex Corporation Recent Development

11.3 Fougera (Sandoz)

11.3.1 Fougera (Sandoz) Company Details

11.3.2 Fougera (Sandoz) Business Overview

11.3.3 Fougera (Sandoz) Ciclopirox Olamine Introduction

11.3.4 Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2020-2025)

11.3.5 Fougera (Sandoz) Recent Development

11.4 Medimetriks Pharmaceuticals

11.4.1 Medimetriks Pharmaceuticals Company Details

11.4.2 Medimetriks Pharmaceuticals Business Overview

11.4.3 Medimetriks Pharmaceuticals Ciclopirox Olamine Introduction

11.4.4 Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025)

11.4.5 Medimetriks Pharmaceuticals Recent Development

11.5 Taro Pharmaceuticals

11.5.1 Taro Pharmaceuticals Company Details

11.5.2 Taro Pharmaceuticals Business Overview

11.5.3 Taro Pharmaceuticals Ciclopirox Olamine Introduction

11.5.4 Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025)

11.5.5 Taro Pharmaceuticals Recent Development

11.6 Preferred Pharmaceuticals

11.6.1 Preferred Pharmaceuticals Company Details

11.6.2 Preferred Pharmaceuticals Business Overview

11.6.3 Preferred Pharmaceuticals Ciclopirox Olamine Introduction

11.6.4 Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025)

11.6.5 Preferred Pharmaceuticals Recent Development

11.7 Ingenus Pharmaceuticals

11.7.1 Ingenus Pharmaceuticals Company Details

11.7.2 Ingenus Pharmaceuticals Business Overview

11.7.3 Ingenus Pharmaceuticals Ciclopirox Olamine Introduction

11.7.4 Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025)

11.7.5 Ingenus Pharmaceuticals Recent Development

11.8 Alvogen (CVC Capital Partners and Temasek )

11.8.1 Alvogen (CVC Capital Partners and Temasek ) Company Details

11.8.2 Alvogen (CVC Capital Partners and Temasek ) Business Overview

11.8.3 Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Introduction

11.8.4 Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2020-2025)

11.8.5 Alvogen (CVC Capital Partners and Temasek ) Recent Development

11.9 Acella Pharmaceuticals

11.9.1 Acella Pharmaceuticals Company Details

11.9.2 Acella Pharmaceuticals Business Overview

11.9.3 Acella Pharmaceuticals Ciclopirox Olamine Introduction

11.9.4 Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025)

11.9.5 Acella Pharmaceuticals Recent Development

11.10 Dr Marc's Manufacturing

11.10.1 Dr Marc's Manufacturing Company Details

11.10.2 Dr Marc's Manufacturing Business Overview

11.10.3 Dr Marc's Manufacturing Ciclopirox Olamine Introduction

11.10.4 Dr Marc's Manufacturing Revenue in Ciclopirox Olamine Business (2020-2025)

11.10.5 Dr Marc's Manufacturing Recent Development

11.11 Paddock Laboratories (Perrigo)

11.11.1 Paddock Laboratories (Perrigo) Company Details

11.11.2 Paddock Laboratories (Perrigo) Business Overview

11.11.3 Paddock Laboratories (Perrigo) Ciclopirox Olamine Introduction

11.11.4 Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2020-2025)

11.11.5 Paddock Laboratories (Perrigo) Recent Development

11.12 Sincerus

11.12.1 Sincerus Company Details

11.12.2 Sincerus Business Overview

11.12.3 Sincerus Ciclopirox Olamine Introduction

11.12.4 Sincerus Revenue in Ciclopirox Olamine Business (2020-2025)

11.12.5 Sincerus Recent Development

11.13 Glades Pharmaceuticals (GSK)

11.13.1 Glades Pharmaceuticals (GSK) Company Details

11.13.2 Glades Pharmaceuticals (GSK) Business Overview

11.13.3 Glades Pharmaceuticals (GSK) Ciclopirox Olamine Introduction

11.13.4 Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2020-2025)

11.13.5 Glades Pharmaceuticals (GSK) Recent Development

11.14 Sterimax

11.14.1 Sterimax Company Details

11.14.2 Sterimax Business Overview

11.14.3 Sterimax Ciclopirox Olamine Introduction

11.14.4 Sterimax Revenue in Ciclopirox Olamine Business (2020-2025)

11.14.5 Sterimax Recent Development

11.15 Guangzhou Kanghe Pharmaceutical

11.15.1 Guangzhou Kanghe Pharmaceutical Company Details

11.15.2 Guangzhou Kanghe Pharmaceutical Business Overview

11.15.3 Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Introduction

11.15.4 Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2020-2025)

11.15.5 Guangzhou Kanghe Pharmaceutical Recent Development

11.16 Tianjin Lisheng Pharmaceutical

11.16.1 Tianjin Lisheng Pharmaceutical Company Details

11.16.2 Tianjin Lisheng Pharmaceutical Business Overview

11.16.3 Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Introduction

11.16.4 Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2020-2025)

11.16.5 Tianjin Lisheng Pharmaceutical Recent Development

11.17 Zhejiang Xianju Pharmaceutical

11.17.1 Zhejiang Xianju Pharmaceutical Company Details

11.17.2 Zhejiang Xianju Pharmaceutical Business Overview

11.17.3 Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Introduction

11.17.4 Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2020-2025)

11.17.5 Zhejiang Xianju Pharmaceutical Recent Development

11.18 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

11.18.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details

11.18.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview

11.18.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Introduction

11.18.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2020-2025)

11.18.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

Apotex Corporation

Fougera (Sandoz)

Medimetriks Pharmaceuticals

Taro Pharmaceuticals

Preferred Pharmaceuticals

Ingenus Pharmaceuticals

Alvogen (CVC Capital Partners and Temasek )

Acella Pharmaceuticals

Dr Marc's Manufacturing

Paddock Laboratories (Perrigo)

Sincerus

Glades Pharmaceuticals (GSK)

Sterimax

Guangzhou Kanghe Pharmaceutical

Tianjin Lisheng Pharmaceutical

Zhejiang Xianju Pharmaceutical

Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

List of Tables

Table 1. Global Ciclopirox Olamine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cream Preparation

Table 3. Key Players of Temperture

Table 4. Key Players of Vaginal Suppository

Table 5. Global Ciclopirox Olamine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Ciclopirox Olamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Ciclopirox Olamine Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Ciclopirox Olamine Market Share by Region (2020-2025)

Table 9. Global Ciclopirox Olamine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Ciclopirox Olamine Market Share by Region (2026-2031)

Table 11. Ciclopirox Olamine Market Trends

Table 12. Ciclopirox Olamine Market Drivers

Table 13. Ciclopirox Olamine Market Challenges

Table 14. Ciclopirox Olamine Market Restraints

Table 15. Global Ciclopirox Olamine Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Ciclopirox Olamine Market Share by Players (2020-2025)

Table 17. Global Top Ciclopirox Olamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclopirox Olamine as of 2024)

Table 18. Ranking of Global Top Ciclopirox Olamine Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Ciclopirox Olamine Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Ciclopirox Olamine, Headquarters and Area Served

Table 21. Global Key Players of Ciclopirox Olamine, Product and Application

Table 22. Global Key Players of Ciclopirox Olamine, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Ciclopirox Olamine Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Ciclopirox Olamine Revenue Market Share by Type (2020-2025)

Table 26. Global Ciclopirox Olamine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Ciclopirox Olamine Revenue Market Share by Type (2026-2031)

Table 28. Global Ciclopirox Olamine Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Ciclopirox Olamine Revenue Market Share by Application (2020-2025)

Table 30. Global Ciclopirox Olamine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Ciclopirox Olamine Revenue Market Share by Application (2026-2031)

Table 32. North America Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Ciclopirox Olamine Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Ciclopirox Olamine Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Ciclopirox Olamine Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Ciclopirox Olamine Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Ciclopirox Olamine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Ciclopirox Olamine Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Ciclopirox Olamine Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Ciclopirox Olamine Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Ciclopirox Olamine Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Ciclopirox Olamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Ciclopirox Olamine Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Ciclopirox Olamine Market Size by Country (2026-2031) & (US$ Million)

Table 47. Bayer Company Details

Table 48. Bayer Business Overview

Table 49. Bayer Ciclopirox Olamine Product

Table 50. Bayer Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 51. Bayer Recent Development

Table 52. Apotex Corporation Company Details

Table 53. Apotex Corporation Business Overview

Table 54. Apotex Corporation Ciclopirox Olamine Product

Table 55. Apotex Corporation Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 56. Apotex Corporation Recent Development

Table 57. Fougera (Sandoz) Company Details

Table 58. Fougera (Sandoz) Business Overview

Table 59. Fougera (Sandoz) Ciclopirox Olamine Product

Table 60. Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 61. Fougera (Sandoz) Recent Development

Table 62. Medimetriks Pharmaceuticals Company Details

Table 63. Medimetriks Pharmaceuticals Business Overview

Table 64. Medimetriks Pharmaceuticals Ciclopirox Olamine Product

Table 65. Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 66. Medimetriks Pharmaceuticals Recent Development

Table 67. Taro Pharmaceuticals Company Details

Table 68. Taro Pharmaceuticals Business Overview

Table 69. Taro Pharmaceuticals Ciclopirox Olamine Product

Table 70. Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 71. Taro Pharmaceuticals Recent Development

Table 72. Preferred Pharmaceuticals Company Details

Table 73. Preferred Pharmaceuticals Business Overview

Table 74. Preferred Pharmaceuticals Ciclopirox Olamine Product

Table 75. Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 76. Preferred Pharmaceuticals Recent Development

Table 77. Ingenus Pharmaceuticals Company Details

Table 78. Ingenus Pharmaceuticals Business Overview

Table 79. Ingenus Pharmaceuticals Ciclopirox Olamine Product

Table 80. Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 81. Ingenus Pharmaceuticals Recent Development

Table 82. Alvogen (CVC Capital Partners and Temasek ) Company Details

Table 83. Alvogen (CVC Capital Partners and Temasek ) Business Overview

Table 84. Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Product

Table 85. Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 86. Alvogen (CVC Capital Partners and Temasek ) Recent Development

Table 87. Acella Pharmaceuticals Company Details

Table 88. Acella Pharmaceuticals Business Overview

Table 89. Acella Pharmaceuticals Ciclopirox Olamine Product

Table 90. Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 91. Acella Pharmaceuticals Recent Development

Table 92. Dr Marc's Manufacturing Company Details

Table 93. Dr Marc's Manufacturing Business Overview

Table 94. Dr Marc's Manufacturing Ciclopirox Olamine Product

Table 95. Dr Marc's Manufacturing Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 96. Dr Marc's Manufacturing Recent Development

Table 97. Paddock Laboratories (Perrigo) Company Details

Table 98. Paddock Laboratories (Perrigo) Business Overview

Table 99. Paddock Laboratories (Perrigo) Ciclopirox Olamine Product

Table 100. Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 101. Paddock Laboratories (Perrigo) Recent Development

Table 102. Sincerus Company Details

Table 103. Sincerus Business Overview

Table 104. Sincerus Ciclopirox Olamine Product

Table 105. Sincerus Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 106. Sincerus Recent Development

Table 107. Glades Pharmaceuticals (GSK) Company Details

Table 108. Glades Pharmaceuticals (GSK) Business Overview

Table 109. Glades Pharmaceuticals (GSK) Ciclopirox Olamine Product

Table 110. Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 111. Glades Pharmaceuticals (GSK) Recent Development

Table 112. Sterimax Company Details

Table 113. Sterimax Business Overview

Table 114. Sterimax Ciclopirox Olamine Product

Table 115. Sterimax Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 116. Sterimax Recent Development

Table 117. Guangzhou Kanghe Pharmaceutical Company Details

Table 118. Guangzhou Kanghe Pharmaceutical Business Overview

Table 119. Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Product

Table 120. Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 121. Guangzhou Kanghe Pharmaceutical Recent Development

Table 122. Tianjin Lisheng Pharmaceutical Company Details

Table 123. Tianjin Lisheng Pharmaceutical Business Overview

Table 124. Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Product

Table 125. Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 126. Tianjin Lisheng Pharmaceutical Recent Development

Table 127. Zhejiang Xianju Pharmaceutical Company Details

Table 128. Zhejiang Xianju Pharmaceutical Business Overview

Table 129. Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Product

Table 130. Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 131. Zhejiang Xianju Pharmaceutical Recent Development

Table 132. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details

Table 133. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview

Table 134. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Product

Table 135. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2020-2025) & (US$ Million)

Table 136. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

Table 140. Authors List of This Report

List of Figures

Figure 1. Ciclopirox Olamine Picture

Figure 2. Global Ciclopirox Olamine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ciclopirox Olamine Market Share by Type: 2024 VS 2031

Figure 4. Cream Preparation Features

Figure 5. Temperture Features

Figure 6. Vaginal Suppository Features

Figure 7. Global Ciclopirox Olamine Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Ciclopirox Olamine Market Share by Application: 2024 VS 2031

Figure 9. Ringworm Of The Body Case Studies

Figure 10. Athlete'S Foot Case Studies

Figure 11. Tinea Case Studies

Figure 12. Tinea Versicolor Case Studies

Figure 13. Candida Albicans Case Studies

Figure 14. Gynecological Anti-Infection Preparation Case Studies

Figure 15. Other Case Studies

Figure 16. Ciclopirox Olamine Report Years Considered

Figure 17. Global Ciclopirox Olamine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Ciclopirox Olamine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Ciclopirox Olamine Market Share by Region: 2024 VS 2031

Figure 20. Global Ciclopirox Olamine Market Share by Players in 2024

Figure 21. Global Top Ciclopirox Olamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclopirox Olamine as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Ciclopirox Olamine Revenue in 2024

Figure 23. North America Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Ciclopirox Olamine Market Share by Country (2020-2031)

Figure 25. United States Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Ciclopirox Olamine Market Share by Country (2020-2031)

Figure 29. Germany Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Ciclopirox Olamine Market Share by Region (2020-2031)

Figure 37. China Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Ciclopirox Olamine Market Share by Country (2020-2031)

Figure 45. Mexico Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Ciclopirox Olamine Market Share by Country (2020-2031)

Figure 49. Turkey Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Ciclopirox Olamine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Bayer Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 53. Apotex Corporation Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 54. Fougera (Sandoz) Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 55. Medimetriks Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 56. Taro Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 57. Preferred Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 58. Ingenus Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 59. Alvogen (CVC Capital Partners and Temasek ) Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 60. Acella Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 61. Dr Marc's Manufacturing Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 62. Paddock Laboratories (Perrigo) Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 63. Sincerus Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 64. Glades Pharmaceuticals (GSK) Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 65. Sterimax Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 66. Guangzhou Kanghe Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 67. Tianjin Lisheng Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 68. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 69. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Ciclopirox Olamine Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350